Back

The additive role of Lp(a) on top of LDL lowering

16 November 2025 (09:00 - 09:15)
Organised by: Logo
Seminar Presentation Part of: Residual Risk after ACS/PCI: It’s not just a matter of LDL Acute Coronary Syndromes, Other Open Access ESC Heart & Stroke 2025 and EuroThrombosis 2025 Council on Stroke

3 More presentations in this session

Presentation thumbnail
Inflammation: from hsCRP to IL1, through IL6
Slides
Presentation thumbnail
Critical appraisal on anti-inflammatory drugs
Presentation thumbnail
Hypertriglyceridemia: combining diet, exercise training and drugs

Access the full session

Session thumbnail
Residual Risk after ACS/PCI: It’s not just a matter of LDL

The Event

Event poster

ESC Heart & Stroke 2025 and EuroThrombosis 2025

16 November 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Extension of coronary artery disease and resistance to lipid-lowering treatment. Value of Lp(a)
23 April 2026
thumbnail
Congress Presentation
Lipoprotein(a) lowering and risk of cardiovascular disease in primary and secondary prevention
29 August 2026
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
6 November 2025
thumbnail
Congress Presentation
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources